In clinical practice, a rise of serum AFP is a well-known suitable serum tumor biomarker used to screen or monitor hepatocellular carcinoma (HCC), tumors of gonadal origin, or yolk sac tumors [3–5]. Here, AFP is linked to hepatocellular carcinoma.